Monocef-O-CV 200/125mg 10 Tablets

babies: not applicable lactating mothers: it is safe to use in lactating mothers. consult the doctor.
pregnancy: it is safe to use during pregnancy. consult the doctor.
driving: it is unsafe to use before driving as it may cause dizziness. alcohol: information is limited.
consult the doctor. kidney: this tablet should be used with caution in patients with kidney disease.
dosage adjustment may be required. consult the doctor before using this medication.
liver: this tablet should be used with caution in patients with liver disease. dosage adjustment may be required.
consult the doctor before using this medication.

Diarrhea Nausea Abdominal pain Vomiting Skin rash Muscle pain.

MONOCEF-O-CV works by preventing the formation of the protective covering of bacteria which is essential for the survival of bacteria. potassium clavulanate is a beta-lactamase inhibitor that decreases resistance and increases the activity of cefpodoxime proxetil against bacteria..

If you miss a dose of MONOCEF-O-CV, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• MONOCEF-O-CV is used to treat bacterial infections. • complete the course of treatment; stopping early may cause resistance.
• this can be taken with food and take plenty of fluids to avoid stomach upset. • stop taking this tablet and inform your doctor immediately if you develop a rash, swelling of the face, throat or tongue or breathing difficulties while taking it.
• do not use remaining medicine for treating any infection in the future. consult the doctor before taking any antibiotic..

• cefpodoxime proxetil, potassium clavulanate + argatroban: concurrent use may increase argatroban's effect. • cefpodoxime proxetil, potassium clavulanate + bivalirudin: concurrent use may lead to the increased effect of bivalirudin.
• cefpodoxime proxetil, potassium clavulanate + enoxaparin: concurrent use may lead to the increased effect of enoxaparin. • cefpodoxime proxetil, potassium clavulanate + warfarin: concurrent use may increase warfarin's effect.
• cefpodoxime proxetil, potassium clavulanate + heparin: concurrent use may increase heparin's effect. • cefpodoxime proxetil, potassium clavulanate + azithromycin: concurrent use may decrease cefpodoxime by pharmacodynamics antagonism..